Trial Profile

Continue Providing Care for Patient Who Participated in the BIA 9-1067-302 Clinical Trial

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 08 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Opicapone (Primary)
Indications Parkinson's disease
Focus Therapeutic Use
Acronyms BIPARK-extension

Most Recent Events

03 Sep 2020 According to a Neurocrine Biosciences media release, data from this trial will be presented at the upcoming virtual scientific meetings, 2020 Psych Congress on September 10 to 13 and the MDS Virtual Congress 2020 on September 12 to 16
12 Mar 2020 Status changed from not yet recruiting to completed.
20 May 2013 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com